ProKidney Corp. (PROK) stock
PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.15+0.02 (+1.77%)
Close on Nov 12, 2026Market cap $347.67MP/E –Yield –
ProKidney operating margin
Operating margin is operating income as a percentage of revenue.
ProKidney's operating margin for the twelve months ending Sep 30, 2026 was -24830.3%. For fiscal 2025 it was -18477.8%, against -241678.9% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -18477.8% | +223201.1 |
| FY2024 | Dec 31, 2024 | -241678.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -30895.4% | −13135.5 |
| Q2 FY2026 | Jun 30, 2026 | -32248.7% | −14280.8 |
| Q1 FY2026 | Mar 31, 2026 | -19881.9% | −1887.1 |
| Q4 FY2025 | Dec 31, 2025 | -20164.9% | +47691.7 |
| Q3 FY2025 | Sep 30, 2025 | -17759.9% | – |
| Q2 FY2025 | Jun 30, 2025 | -17967.9% | – |
| Q1 FY2025 | Mar 31, 2025 | -17994.8% | – |
| Q4 FY2024 | Dec 31, 2024 | -67856.6% | – |
See a number that looks wrong?